pre-IPO PHARMA

COMPANY OVERVIEW

biomarck is a biopharmaceutical company with a patented technology platform. We are developing a portfolio of products utilizing targeted anti-Marcks technology for the treatment of Cancer and Acute Respiratory Distress Syndrome (ARDS).


LOCATION

  • Durham, NC, USA

  • THERAPEUTIC AREAS

  • Inflammatory Disease
  • Oncology
  • Respiratory Disease

  • WEBSITE

    https://www.biomarck.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Mar 8, 2021

    Biomarck Pharmaceuticals presents at H.C. Wainwright 2021 Global Life Sciences Conference on March 9-10, 2021


    Jun 1, 2020

    Biomarck Pharmaceuticals to Present Expanded Analysis of BIO-11006 Clinical Data in Treatment of Non-Small Cell Lung Cancer at the American Thoracic Society 2020 International Conference


    Jan 10, 2020

    Biomarck Pharmaceuticals to Participate in 38th Annual J.P. Morgan Healthcare Conference on Thursday, January 16th, 2020


    Sep 20, 2016

    Live Like Bella® & Biomarck Pharmaceuticals launch partnership to offer innovative inhaled medication to children battling cancer


    For More Press Releases


    Google Analytics Alternative